The Evolution of Clinical Development for TIL Cell Therapy in Solid Tumors

Time: 10:00 am
day: Day One


  • Delivering broader access to TIL through multi-center studies and scalable manufacturing
  • Clinical Data for TIL in metastatic melanoma, metastatic non-small cell lung and advanced cervical cancers
  • Clinical data for TIL in combination with other therapies in earlier cancer treatment settings
  • Research on genetically-modified TIL as a next-generation approach